(Q46253684)

English

Dasatinib medication causing profound immunosuppression in a patient after haploidentical SCT: functional assays from whole blood as diagnostic clues.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Dasatinib medication causing profound immunosuppression in a patient after haploidentical SCT: functional assays from whole blood as diagnostic clues (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

immunosuppression

1 reference

based on heuristic

inferred from title

dasatinib monohydrate

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Matthias Eyrich

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

M Wölfl

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

F Langhammer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

V Wiegering

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

P G Schlegel

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

language of work or name

0 references

publication date

10 December 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

48

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

875-877

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

https://scigraph.springernature.com/pub.10.1038/bmt.2012.246

0 references

Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

The Src/ABL kinase inhibitor dasatinib (BMS-354825) inhibits function of normal human T-lymphocytes in vitro

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

Dasatinib exerts an immunosuppressive effect on CD8+ T cells specific for viral and leukemia antigens

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

Dasatinib inhibits recombinant viral antigen-specific murine CD4+ and CD8+ T-cell responses and NK-cell cytolytic activity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

Lck is a key target of imatinib and dasatinib in T-cell activation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

Profound inhibition of antigen-specific T-cell effector functions by dasatinib

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

Immunoprofiling of patients with chronic myeloid leukemia at diagnosis and during tyrosine kinase inhibitor therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

Primed tumor-reactive multifunctional CD62L+ human CD8+ T cells for immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46253684&oldid=1584492865"